{
  "id": 3101760,
  "title": "Bausch + Lomb plans Ph3 trial for dry eye drop, despite missing mid-stage goal",
  "url": "https://urgent.news/2026/08/24/bausch-lomb-plans-ph3-trial-for-dry-eye-drop-despite-missing-mid",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-24T20:00:33.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/bausch-lomb-plans-ph-3-trial-for-dry-eye-drop-despite-missing-mid-stage-goal/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Bausch + Lomb’s dual-action drop for dry eye failed a Phase 2 study, the company exclusively told Endpoints News on Monday. But CEO Brent Saunders claims it was a \"better outcome than we had ever hoped ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}